{"filing":{"accession_number":"0001104659-26-109814","cik":"0001175151","ticker":"CTSO","company_name":"Cytosorbents Corp","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-22","primary_document":"tm2625982d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465926109814/tm2625982d1_8k.htm"},"events":[{"id":34473,"run_id":31719,"accession_number":"0001104659-26-109814","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"CytoSorbents regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) as of September 22, 2026, after 10 consecutive trading sessions at or above that threshold. However, the company remains non-compliant with the Market Value of Listed Securities (MVLS) requirement of $35 million and has until December 28, 2026 to regain compliance or face delisting notification.","company_name":"Cytosorbents Corp","ticker":"CTSO","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38201,"accession_number":"0001104659-26-109814","item_number":"7.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"CytoSorbents announced regaining compliance with Nasdaq's minimum bid price requirement ($1.00 per share) after receiving notification on September 22, 2026, that the closing bid price had been $1.00 or greater for 10 consecutive trading sessions. However, the company explicitly acknowledges it is \"working towards full compliance with Nasdaq's Capital Market listing requirements by addressing the minimum Market Value of Listed Securities requirement...before the December 28, 2026 compliance date,\" indicating ongoing delisting risk on a separate metric. This disclosure directly addresses listing compliance status and the threat of delisting.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T11:33:08.636167+00:00","company_name":"","ticker":null,"filing_date":""},{"id":38202,"accession_number":"0001104659-26-109814","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that CytoSorbents regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) as of September 22, 2026, but remains non-compliant with the Market Value of Listed Securities (MVLS) requirement of $35 million. The company has until December 28, 2026 to regain compliance or face delisting notification. This is a material delisting risk disclosure under Item 8.01, as the company explicitly states \"There can be no assurance that the Company will regain compliance with the MVLS Requirement or otherwise maintain the listing of its common stock on the Nasdaq Capital Market.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T11:33:08.636167+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38201,"accession_number":"0001104659-26-109814","item_number":"7.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"CytoSorbents announced regaining compliance with Nasdaq's minimum bid price requirement ($1.00 per share) after receiving notification on September 22, 2026, that the closing bid price had been $1.00 or greater for 10 consecutive trading sessions. However, the company explicitly acknowledges it is \"working towards full compliance with Nasdaq's Capital Market listing requirements by addressing the minimum Market Value of Listed Securities requirement...before the December 28, 2026 compliance date,\" indicating ongoing delisting risk on a separate metric. This disclosure directly addresses listing compliance status and the threat of delisting.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T11:33:08.636167+00:00","company_name":"Cytosorbents Corp","ticker":"CTSO","filing_date":"2026-09-23"},{"id":38202,"accession_number":"0001104659-26-109814","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that CytoSorbents regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) as of September 22, 2026, but remains non-compliant with the Market Value of Listed Securities (MVLS) requirement of $35 million. The company has until December 28, 2026 to regain compliance or face delisting notification. This is a material delisting risk disclosure under Item 8.01, as the company explicitly states \"There can be no assurance that the Company will regain compliance with the MVLS Requirement or otherwise maintain the listing of its common stock on the Nasdaq Capital Market.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T11:33:08.636167+00:00","company_name":"Cytosorbents Corp","ticker":"CTSO","filing_date":"2026-09-23"}]}